Adial Pharmaceuticals Statistics
Total Valuation
ADIL has a market cap or net worth of $4.40 million. The enterprise value is -$622,468.
| Market Cap | 4.40M |
| Enterprise Value | -622,468 |
Important Dates
The next estimated earnings date is Monday, August 19, 2024, before market open.
| Earnings Date | Aug 19, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ADIL has 4.23 million shares outstanding. The number of shares has increased by 179.05% in one year.
| Shares Outstanding | 4.23M |
| Shares Change (YoY) | +179.05% |
| Shares Change (QoQ) | +107.34% |
| Owned by Insiders (%) | 3.87% |
| Owned by Institutions (%) | 4.17% |
| Float | 4.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.72 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.48, with zero debt.
| Current Ratio | 9.48 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -219.20% and return on invested capital (ROIC) is -105.60%.
| Return on Equity (ROE) | -219.20% |
| Return on Assets (ROA) | -192.50% |
| Return on Capital (ROIC) | -105.60% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.17M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.88% in the last 52 weeks. The beta is 1.29, so ADIL's price volatility has been higher than the market average.
| Beta (5Y) | 1.29 |
| 52-Week Price Change | -79.88% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 1.78 |
| Relative Strength Index (RSI) | 34.99 |
| Average Volume (20 Days) | 221,406 |
Short Selling Information
The latest short interest is 218,184, so 5.15% of the outstanding shares have been sold short.
| Short Interest | 218,184 |
| Short Previous Month | 163,390 |
| Short % of Shares Out | 5.15% |
| Short % of Float | 5.30% |
| Short Ratio (days to cover) | 0.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -6.46M |
| Pretax Income | -8.69M |
| Net Income | -8.69M |
| EBITDA | -8.71M |
| EBIT | -8.69M |
| Earnings Per Share (EPS) | -$3.15 |
Balance Sheet
The company has $5.03 million in cash and no debt, giving a net cash position of $5.03 million or $1.19 per share.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | n/a |
| Net Cash | 5.03M |
| Net Cash Per Share | $1.19 |
| Equity (Book Value) | 6.12M |
| Book Value Per Share | 1.45 |
| Working Capital | 4.77M |
Cash Flow
| Operating Cash Flow | -6.13M |
| Capital Expenditures | n/a |
| Free Cash Flow | -6.13M |
| FCF Per Share | -$2.08 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ADIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -179.05% |
| Shareholder Yield | -179.05% |
| Earnings Yield | -197.47% |
| FCF Yield | -139.33% |
Analyst Forecast
The average price target for ADIL is $150.00, which is 14,323.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $150.00 |
| Price Target Difference | 14,323.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -49.15% |
Stock Splits
The last stock split was on August 7, 2023. It was a reverse split with a ratio of 1:25.
| Last Split Date | Aug 7, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |